Amanote Research
Register
Sign In
Figure 3: Nomogram to Predict 3- And 5-Year Overall Survivals in Patients With Pelvic Ewing Sarcoma.
doi 10.7717/peerj.7710/fig-3
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 4: Calibration Curves of the Nomogram Predicting (A) 3-Year and (B) 5-Year Overall Survivals in Patients With Pelvic Ewing Sarcoma.
Figure 2: Prognostic Nomogram to Predict Patient’s ESRD Rate in 3 Years in Patients With Diabetic Nephropathy.
Figure S2: The Calibration Curves Predicting Overall Survival at (A) 3-Year and (B) 5-Year
Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pelvic Chondrosarcoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Figure 5: Performance of Nine-lncRNA Prognostic Signature in Model Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
Table 1: Patient Characteristics and 3- And 5-Year Overall Survival Rates.
Pre-Treatment CT Radiomics to Predict 3-Year Overall Survival Following Chemoradiotherapy of Esophageal Cancer
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Figure 8: Performance of Nine-lncRNA Prognostic Signature in Validation Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
A Nomogram to Predict Overall Survival for Biliary Tract Cancer
Cancer Management and Research
Oncology
